IMPORTANCE Fetal alcohol spectrum disorders are costly, life-long disabilities. Older data suggested the prevalence of the disorder in the United States was 10 per 1000 children; however, there are few current estimates based on larger, diverse US population samples.
F etal alcohol spectrum disorders, composed of fetal alcohol syndrome, partial fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder, are leading causes of developmental disabilities worldwide. [1] [2] [3] The commonly accepted estimate for the United States of 10 per 1000 children affected was derived from clinic-based studies or studies of single communities using small samples and different research methods. [4] [5] [6] Estimating the prevalence of fetal alcohol spectrum disorders is challenging using routine surveillance methods; one recent US study suggested that children with fetal alcohol spectrum disorders are frequently not diagnosed (80%) or misdiagnosed (7%). 7 As a result, standard methods of passive record surveillance or clinic-based studies may have led to underestimates. [1] [2] [3] 6 By contrast, active-case ascertainment methods that have been applied in several other countries have resulted in higher prevalence estimates. [8] [9] [10] [11] Similarly, a 2007-2009 single-site, active-case ascertainment study 12 conducted in US communities showed a prevalence rate for fetal alcohol syndrome and partial fetal alcohol syndrome of 10.0 per 1000 children; another 2010-2011 single site, active-case ascertainment study 13 showed a prevalence rate for fetal alcohol spectrum disorders of 24.0 per 1000 children. These data have highlighted the need for a larger study with broader representation of US communities with general population samples. In 2010, the US National Institute on Alcohol Abuse and Alcoholism initiated the Collaboration on Fetal Alcohol Spectrum Disorders Prevalence consortium, which was challenged to use the best available research methods to establish prevalence estimates in US communities.
14 These data are needed to help determine the public health burden, identify the need for clinical resources, and establish a baseline prevalence against which to measure progress in prevention. 15 This article describes the prevalence of fetal alcohol spectrum disorders across 4 US sites using an active caseascertainment approach and applying standardized consensus criteria for case classification.
Methods
Two research teams, both funded by the National Institute on Alcohol Abuse and Alcoholism to establish the consortium, 16 were charged with determining the prevalence of fetal alcohol spectrum disorders in US communities using similar sampling methods and identical assessment and classification criteria. To this end, the investigators were asked to establish and implement a common set of standards to define fetal alcohol spectrum disorders, including full or partial fetal alcohol syndrome and alcohol-related neurodevelopmental disorder.
Study Design
Active-case ascertainment with a cross-sectional design was used at 4 community sites, a convenience sample that was selected based on the investigators' ability to engage the individual communities and on the feasibility of conducting the study in that community. In each site, first-grade children in public and private schools were recruited across 2 academic years, yielding 8 independent samples. Data collection took place between November 15, 2010, and July 12, 2016.
Study Population, Ethics, and Assessment of Participants
Four study sites, representing diverse areas of the United States, included a Midwest community with a population of 172 000, a Rocky Mountain site with a population of 60 000, a Southeast site with a population of 206 000, and an urban city in the Pacific Southwest with a population of 1.4 million 17 (for additional demographic details, see eTable 1 in the Supplement). The specific locations of the sites could not be disclosed due to confidentiality requirements of the community and school administrators at the sites. Study approvals were secured from school administrators at each site, and institutional review board approvals were obtained at the investigators' respective academic institutions. Federal certificates of confidentiality were obtained from the National Institutes of Health. Parents or guardians provided oral or written informed consent for screening and written consent for full evaluations; children 7 years or older provided written assent. Participants were provided monetary and nonmonetary incentives for study completion that were commensurate with the amount of time and travel required to complete the study. Parents or guardians received summary information on their child's evaluations and were provided referrals for services.
Assessment tools were selected for the 4 domains germane to the spectrum of fetal alcohol spectrum disorders: growth, dysmorphology, neurodevelopment, and prenatal alcohol exposure.
Dysmorphology was evaluated by a team of experienced dysmorphologists or clinical geneticists. The dysmorphologists were blinded to the child's prenatal alcohol history and neurodevelopmental performance at the time of the examinations. Children were measured for weight, height, and head circumference and were evaluated for the facial features of fetal alcohol syndrome and other minor anomalies using a standard checklist (eFigure 1intheSupplement). Neurodevelopmental performance was assessed by school psychologists or study psychometrists using a cognitive and behavioral testing battery of standardized, ageappropriate instruments available in English and Spanish and suitable for single-session administration. The selected tests evaluated cognition, academic achievement, behavior, and adaptive skills (eFigure 2 in the Supplement).
Prenatal alcohol exposure was assessed through maternal interviews conducted by trained study staff, in person or over the telephone. Alcohol consumption questions were embedded in a common core of queries regarding maternal health. Specific questions assessed alcohol use prior to pregnancy recognition and during pregnancy, by quantity, frequency, and gestational timing. Social, legal, or medical problems related to alcohol were included as indicators of alcohol use. Interview data were collected from consented collateral sources, such as a close relative, if the biological mother was absent. Cofactors of maternal risk were also captured, including demographics, prenatal care, maternal nutrition, and tobacco and recreational drug use. Preexisting neurobehavioral diagnoses were elicited from parents or guardians. Race/ethnicity was captured as one of the demographic characteristics for an epidemiological study. Race/ethnic group was obtained from the parent or guardian of the participating child and categorized according to predefined National Institutes of Health categories.
Standardized Classification Criteria
Classification criteria based on facial features, growth, and child performance were selected by consensus among consortium members. The clinical criteria were consistent with the published "Updated clinical guidelines for diagnosing fetal alcohol spectrum disorders." 18 However, as applied in this epidemiological study, a less stringent cutoff of more than 1 standard deviation below the mean for specific learning impairment was used as 1 of the criteria for fetal alcohol spectrum disorders. This modification was adopted by the consortium to represent a balance of sensitivity and specificity for classification among children in the first-grade age range (eBox in the Supplement). Cutoff criteria defining risky levels of alcohol consumption in pregnancy were also established. Although documented alcohol exposure was not required when children had sufficient physical traits to be classified as having full or partial fetal alcohol syndrome, alcohol exposure during pregnancy at the predefined cutoff levels was required for alcoholrelated neurodevelopmental disorder.
Sampling Methods
Sampling and consenting processes varied across sites and academic years based on local agreement, school access requirements, and policies resulting in the different sampling methods that were used (Figure) .
In sampling method 1, used at the Midwest and Rocky Mountain sites, all elementary schools in the school district participated. At the Southeastern county site, all 5 schools in 1 school district participated; in the second school district in the county, 9 of 19 elementary schools were randomly selected for participation. All first-grade children whose parents or guardians allowed their child to participate were measured for weight, height, and head circumference. Those whose measurements were at the 25th percentile or lower received a dysmorphology examination. In addition, a random sample of all children enrolled in first-grade classes was selected, and those whose parent or guardian granted permission for their participation received a dysmorphology examination. Those children who exhibited alcohol-related physical features on the dysmorphology examination and all randomly selected children went on to receive neurobehavioral testing, and their mothers or collaterals were asked to complete interviews. In addition, when a twin was selected for full evaluation by any of the established screening criteria, his/her co-twin was also selected for full evaluation. Similarly, children referred by their teacher or repeating first grade were also selected for full evaluation (Figure) .
In sampling method 2, no screening was undertaken. A simple random sample was selected from first-grade children enrolled at all elementary schools in the community. All selected children with consent were offered the full evaluation, including the dysmorphology examination, neurobehavioral testing, and the maternal or collateral interview.
In sampling method 3, the large population of the Pacific Southwestern site required that a subsample of schools be selected. A convenience sample of 27 schools was selected to participate. Of these, 25 were selected from the 120 regular elementary schools and 1 from the 26 charter schools in the public school district. In addition, 1 of the 55 private or special needs schools in the city participated. These schools were identified as representing diverse socioeconomic and geographic areas and were led by school principals who indicated willingness to participate in the study. From these schools, parents or guardians were first asked for written permission to be contacted. Among those who agreed to be contacted, consent was obtained for screening for weight, height, or head circumference that was at or lower than the 25th percentile. In addition, a child development screening tool, Parents Evaluation of Development Status, 19 was administered to each participating parent or guardian. A report of 2 or more developmental concerns was considered a positive screen result. A random sample was drawn from participating children who had negative results for both growth and the Parents Evaluation of Development Status. Children who had positive screen results and those who had been selected among the group who had negative screen results were then invited, if their parents or guardians agreed, to receive the dysmorphology examination, neurobehavioral testing, and the maternal or collateral interview. In addition, co-twins and teacher referrals or children repeating first grade were eligible for the full evaluation as described in sampling method 1.
In sampling methods 1 and 3, the strategy of initial screening on growth, developmental concerns, or both narrowed the pool of children eligible for the full fetal alcohol spectrum disorders evaluation. This allowed for more efficient use of resources by only providing full evaluations to those children who could have met 1 of the required criteria for 1 or more classifications. This strategy was coupled with a random sampling to include children not selected through the screening process. This additional strategy provided the opportunity to identify children who would have been missed on either screening measure, particularly those children who may have alcoholrelated neurodevelopmental disorder.
Consistent Application of Criteria
The collective data on all evaluated children were reviewed by the respective study teams in case conferences, and a fetal alcohol spectrum disorder classification was assigned (see the eBox in the Supplement). The 2 study teams also exchanged information and assigned a second independent classification to each qualifying case and a sample of noncases to ensure consistent and accurate application of fetal alcohol spectrum disorders criteria for all children.
Statistical Analysis
Prevalence was estimated in 2 ways. The first method estimated the minimum or most conservative prevalence and 95% CIs using the total number of children classified within the fetal alcohol spectrum disorders continuum for a given sample as the numerator and the total number of eligible children at that site for that year as the denominator. In sampling methods 1 and 3, the term eligible children was defined as all children enrolled in the participating first-grade classes in that year. In sampling method 2, the denominator was defined as the total number of children who were selected randomly at each site (consented and not consented). The conservative approach assumed that children who were not evaluated did not have fetal alcohol spectrum disorders. These prevalence estimates represented the minimum prevalence for a community in a given year (formulas are in the Formulas for Calculation of the Prevalence by Sampling Method section of the Supplement). The second set of estimates used a weighting technique to consistently estimate the prevalence and 95% CIs accounting in sampling methods 1 and 3 for the proportions of children who screened positive for growth or developmental concerns or who were randomly selected and restricting the denominators in all 3 sampling methods to children with sufficient information to be classified as having a fetal alcohol spectrum disorder. In this approach data were assumed to be missing completely at random, ie, children who were not evaluated had the same prevalence of fetal alcohol spectrum disorders as those completing the evaluation. This included children not consented and those who did not complete all components of the evaluation. Open-source statistical programming language and environment R version 3.4.1 was used.
Weighted estimates of the prevalence of fetal alcohol spectrum disorders and its continuum of specific diagnoses were generally of the form Σ J j=1 w j X j /n j , for which J represents the number of subpopulations from which the samples were drawn; X j represents the number of children with fetal alcohol spectrum disorders or other specific diagnosis identified among the n j children who had been fully evaluated and drawn from subpopulation j, w j = N j /N, for which N j represents the size of the subpopulation j; and N represents the size of the total population so that Σ J j= 1 w j = 1. This is equivalent to weighting by the inverse probability of sampling. As a special case, in sampling method 2, for which simple random sampling was used, J = 1 and w 1 = 1. In sampling method 1, J = 3 for both full and partial fetal alcohol syndrome, and the subpopulations were (1) small (ie, weight, height, or head circumference ≤25th percentile), (2) not small, and (3) twin or referral. For alcoholrelated neurodevelopmental disorder and total fetal alcohol spectrum disorders in sampling method 1, J = 4 and the subpopulations were (1) small and with alcohol-related physical features, (2) small but without alcohol-related physical features, (3) not small, and (4) twin or referral. For total fetal alcohol spectrum disorders and for j =2, X 2 was the number of children with alcohol-related neurodevelopmental disorder in the corresponding subsample. In sampling method 3, J = 2, and the subpopulations were (1) positive screen result and (2) negative screen result. More computational details, sampling diagram, and a working example are provided in the Formula for Calculation of the Prevalence by Sampling Method section and eFigure 3 of the Supplement.
To obtain CIs for the prevalence estimates, the variance of the estimated prevalence was estimated by Σ J j=1 w 2 j var (p_hat), for which p j = X j /n j . For sampling methods 1 and 2, var(p j )=p j (1−p j )/n j . For sampling method 3, cluster sampling (for which cluster indicates school) was accounted for using nonparametric bootstrap, by resampling with replacement clusters (ie, schools) with 10 000 bootstrap runs. Log-log transformation and normal approximation were then used to obtain CIs of the prevalence. See the Variance Estimates and Confidence Intervals section in the Supplement.
Results
Participating classrooms had an enrollment of 13 146 children over all years. Of these, 6054 children were screened on growth, development, or both. An additional 585 were randomly selected in the sampling method 2 sites to receive the dysmorphology examination. A total of 3083 dysmorphology examinations were provided, 1898 maternal or collateral interviews were completed, 2173 children completed the cognitivebehavioral battery, and 2962 children were evaluated for a fetal alcohol spectrum disorder classification in case conferences (eTable 2 in the Supplement). Data from 1 academic year (2010-2011) in the first Midwestern sample have been published 13 but were incorporated into the overall prevalence estimates using the more current consortium criteria for classification. Consent rates for screening among eligible children ranged from 36.9% to 92.5% and averaged 59.9% across all sites. Characteristics of the mothers who completed the maternal interview and their children by site are shown in Table 1 . Sampling method 1 was used at 3 sites, 2 for only 1 academic year and 1 for both academic years. Sampling method 2 was used at 2 sites for 1 academic year each. Sampling method 3 was used at 1 site for both academic years ( Table 2) .
Applying the study diagnostic criteria across all samples, 222 children were classified with a fetal alcohol spectrum disorder. Of these, 27 met criteria for fetal alcohol syndrome, 104 met criteria for partial fetal alcohol syndrome, and 91 met criteria for alcohol-related neurodevelopmental disorder (Table 2) . Only 2 of the 222 children classified with a fetal alcohol spectrum disorder had been diagnosed previously with the disorder, although many parents and guardians were aware of the learning and behavioral challenges facing their children.
The conservative prevalence estimates and 95% CIs for fetal alcohol spectrum disorders for the samples across all study sites are presented in Table 2 . The total number of fetal alcohol spectrum disorder cases in the numerator for sampling method 1 was 103 children; for sampling method 2, 28 children; and for sampling method 3, 91 children. The prevalence estimates varied by sample, site, and sampling method. The conservative estimate of fetal alcohol spectrum disorders prevalence ranged from a low of 11.3 (95% CI, 7.8-15.8) per 1000 children in 1 Midwestern sample to a high of 50.0 (95% CI, 39.9-61.7) per 1000 children in 1 Rocky Mountain sample.
Total estimated prevalence of fetal alcohol spectrum disorders using the weighted approach ranged from a low of 31.1 per 1000 children (95% CI, 16.1-54.0) in 1 Southeastern sample to a high of 98.5 per 1000 children (95% CI, 57.5-139.5) in 1 Rocky Mountain sample ( Table 3) . Fetal alcohol spectrum disorders prevalence estimates using the weighted approach were substantially higher than the conservative estimates due to the use of denominators restricted to those children who had received a full evaluation. These restricted denominators represented between 19% and 50% of the larger eligible number of children used as the denominators for the more conservative estimates. The weighted estimates assumed that the estimated prevalence of fetal alcohol spectrum disorders among evaluated children was applicable to those children not evaluated.
With respect to the specific categories, shown in Table 3 , the weighted prevalence estimates for fetal alcohol syndrome ranged from 0 (95% CI, 0.00-12.7) to 7.8 (95% CI, 4.2-13.5) per 1000 children and accounted for less than 20% of the overall prevalence of fetal alcohol spectrum disorders in any sample. The prevalence estimates for partial fetal alcohol syndrome ranged from 8.4 (95% CI, 0.0-20.2) to 59.1 (95% CI, 26.7-91.6) per 1000 children. The prevalence estimates for alcoholrelated neurodevelopmental disorder ranged from 9.7 (95% CI, 2.1-30.4) to 50.4 (95% CI, 25.3-88.3) per 1000 children.
Within sampling strategy, the weighted prevalence estimates for fetal alcohol spectrum disorders in sampling methods 1 and 3 were more consistent with overlapping CIs. Sampling method 2 produced the most divergent fetal alcohol spectrum disorder prevalence estimates with CIs that did not overlap.
Discussion
The primary finding was a conservatively estimated prevalence of fetal alcohol spectrum disorders across 4 sites in the United States that ranged from 11.3 (95% CI, 7.8-15.8) to 50.0 (95% CI, 39.9-61.7) per 1000 children. Using a weighted prevalence approach with the denominator restricted to children who received a full evaluation and therefore had a defined outcome, estimates across the same 4 communities were substantially higher. Prevalence estimates using this approach ranged from 31.1 (95% CI, 16.1-54.0) to 98.5 (95% CI, 57.5-139.5) per 1000 children.
Three recent systematic reviews and meta-analyses of global data on the worldwide prevalence of fetal alcohol syndrome or fetal alcohol spectrum disorders have been published. [1] [2] [3] However, there were few US studies included in these meta-analyses, and those studies that met criteria for inclusion were predominately clinic based or used passive surveillance. All previous studies were conducted at single sites, and only 5 used complete active case ascertainment, including 1 sample that was incorporated into the present study. 13 Among the 5 active case ascertainment studies included in these meta-analyses, varying diagnostic criteria were used to classify cases, and only 1 study assessed children for alcoholrelated neurodevelopmental disorder. This consortium study, to our knowledge, was the first to apply active case ascertainment, common methodology, a single classification system and expert in-person evaluation for a continuum of fetal alcohol spectrum disorders including alcohol-related neurodevelopmental disorder to a large number of children from communities across the United States. These prevalence estimates are consistent with mounting evidence that harmful fetal alcohol exposure is common in the United States today [20] [21] [22] [23] [24] [25] [26] [27] and highlight the public health burden due to fetal alcohol spectrum disorders. Placed in the context of another common developmental disorder, the Centers for Disease Control and Prevention estimated in 2012 that the prevalence of autism spectrum disorders among b Number of children classified is the number of children reviewed in case conferences. Those with sufficient information from the full evaluation to classify as fetal alcohol spectrum disorders are included in the denominators for the weighted prevalence estimates.
c Consists of 1 county that included 3 midsized to small cities and rural areas. a Conservative prevalence estimated by number of cases per the number of eligible children × 1000.
b Eligible children were defined as all children enrolled in first-grade classes for sampling methods 1 and 3 and all children enrolled in first-grade classes who were randomly selected for sampling method 2.
c The total number of children enrolled in first grade for sample 2 was 2014, from which 709 were randomly selected for participation in the study; the total number of children enrolled in first grade for sample 4 was 888, from which 400 were randomly selected for participation in the study. 26 A pattern of binge drinking in pregnancy is thought to present the highest risk of fetal alcohol spectrum disorders among offspring. In this study, 2 of 222 children with fetal alcohol spectrum disorders were known to have been previously diagnosed with the disorder. These data confirm that missed diagnoses and misdiagnoses of children are common. 7 Similarly, in a previous school-based US sample, only 1 of 7 children identified with fetal alcohol syndrome had a previous diagnosis 29 ; in another, only 2 of 26 children identified with full or partial fetal alcohol syndrome had a previous diagnosis. 12 This study has several strengths. First, active case ascertainment was used in first-grade cohorts to obtain general population prevalence data in 4 communities. Second, the 5-to 7-year age range was optimal for identification of physical features associated with fetal alcohol spectrum disorders and suitable for early evaluation of neurobehavioral problems linked to alcohol exposure. Third, children were identified using face-to-face, blinded examinations provided by dysmorphologists with extensive experience in fetal alcohol spectrum disorders and the ability to rule out other disorders with similar phenotypes. Fourth, standardized neurobehavioral testing was conducted in a blinded manner by locally certified examiners. Fifth, maternal and collateral interviews used validated techniques for capturing detailed information on alcohol use in pregnancy and maternal risks. Sixth, a priori common criteria for classification were agreed upon by multidisciplinary researchers and advisors for the consortium, and they were applied consistently across sites. In addition, data were collected in such a manner that other diagnostic schema for fetal alcohol spectrum disorders that are currently in use or that are developed in the future could be applied.
Limitations
This study has several limitations. First, due to local policy variations in the modes of access allowed for recruitment of children, as well as variability in willingness to consent, no individual sample evaluated the entire eligible population. Consent rates for screening ranged from 36.9% to 92.5% in individual samples and overall consent rates for screening averaged only 59.9% of eligible children (eTable 2 in the Supplement). If nonconsented children differed from consented, this could have biased prevalence estimates in either direction. Second, the numbers of cases of each category of fetal alcohol spectrum disorders in each sample are small, leading to wide CIs. Third, neurobehavioral testing at this age may have missed some children with deficits that would not become apparent until later ages, which could have led to underestimation of rates. Fourth, this crosssectional study was neither a longitudinal nor a clinical sample. More comprehensive, repeated measures at older ages may have identified more children. This limitation highlights the need for longitudinal prevalence studies. Fifth, the criteria defining neurobehavioral impairment in this study were selected to balance sensitivity for deficits that have functional consequences with specificity for the characteristic neurobehavioral domains known to be affected by prenatal alcohol exposure. The objective was to produce prevalence estimates across multiple communities using a one-time evaluation to identify children with measurable deficits consistent with prenatal alcohol exposure. However, in the absence of a definitive biomarker for fetal alcohol spectrum disorders, it is impossible to know what proportion of these deficits were caused by fetal alcohol exposure. Therefore, prevalence estimates, particularly for alcoholrelated neurodevelopmental disorder, could be overestimated. In addition, the 4 communities in this study may not be representative of the United States overall. The sample-bysample variability in prevalence estimates may be due in part to the low absolute number of children classified in each category of fetal alcohol spectrum disorders. However, variability across sites may also be representative of the diversity that would be seen elsewhere, similar to the variability in risky alcohol consumption reported among women across the United States. 26, 27 Conclusions Estimated prevalence of fetal alcohol spectrum disorders among first-graders in 4 US communities ranged from 1.1% to 5.0% using a conservative approach. These findings may represent more accurate US prevalence estimates than previous studies, but may not be generalizable to all communities. Role of the Funder/Sponsor: As a part of its role as one voting member of the CoFASP cooperative agreement steering committee, the NIAAA supported the design and conduct of the study; interpretation of the data; review and approval of the manuscript; and participated in the decision to submit the manuscript for publication.
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IV. Alcohol Consumption Criteria
One or more of the following conditions must be met to constitute documented prenatal alcohol exposure during pregnancy. The information must be obtained from the biological mother or a reliable collateral source (eg, family member, social service agency, or medical record)
A. 6 or more drinks per week for 2 or more weeks during pregnancy B. 3 or more drinks per occasion on 2 or more occasions during pregnancy C. Documentation of alcohol-related social or legal problems in proximity to (prior to or during) the index pregnancy (eg, history of multiple citations for driving while intoxicated or history of treatment for an alcohol-related condition)
aModified from Hoyme et al, 2016
5
Sample Characteristics
Demographic and other descriptors of the general population at the four participating sites as well as the same descriptors for the US population as a whole in 2015 are shown in eTable1. Sample sizes of each cohort, consent rates, and number of evaluations completed in each domain are described in eTable2.
Sampling Methods
A complete census (evaluation of all individuals in the selected study regions with respect to FASD), although theoretically ideal, was not feasible in the consortium, due in part to the extensive resources required to accomplish the needed child and maternal assessments. Instead, other methods for evaluating a sample of the population were employed, including random sampling in some settings and a screening approach in others. In the latter scenario, a larger sample (oversample) of children was screened on key criteria associated with prenatal alcohol exposure (i.e., growth or developmental concerns) and only those meeting the "high risk" screening criteria were selected for full evaluation. An additional sample of children who did not meet the screening criteria were also selected for full evaluation for purposes of creating control/comparison groups of children in each community. These comparison children represented the distribution of physical features, growth, and cognitive and behavioral functioning within each study community.
Three methods were used in the consortium sites for sampling. In some settings, the choice of method was due to practical issues. However, variability in the sampling techniques within or across sites provided the opportunity to evaluate the efficacy, practicality, and efficiency of different techniques of sampling. Each of the three methods are described below and outlined in the Figure in the main paper.
Sampling Method 1 (SM1): Oversample of Small Children with a Randomly-Selected Comparison Group from All Eligible Children
In this method, a tiered approach was used to most efficiently evaluate children in the study sample, and to provide a census or oversample of all small children. By oversampling the small children, the rationale was to increase the likelihood of identifying children with FAS or pFAS, as growth (weight, height or head circumference ≤10 th centile) are features that contribute to these two FASD classification categories. Permission was sought and obtained from parents/guardians for each child enrolled in first grade in all community schools at the site to participate in screening on weight, height and head circumference. Any child who met the criteria of ≤25 th centile on any one growth measure using the standard Centers for Disease Control and Prevention growth charts 1 was advanced to receive the physical examination by study dysmorphologists. Small children who had alcohol-related physical features identified in the dysmorphology examination went on to receive neurobehavioral evaluation and their mothers or collateral representatives were interviewed for maternal risk factors including extensive questions regarding alcohol consumption. In addition, randomly selected candidates for the comparison groups were drawn via random number generation programs from the entire pool of children enrolled in the first-grade classes of each school. All randomly-selected candidates who had been consented into the study were evaluated for all four relevant domains: growth; dysmorphology; neurobehavior; and maternal risk factors, especially drinking alcohol in pregnancy (see the Figure in the main paper) .
In addition to screening on growth, case identification in SM1 was supplemented by teacher referrals of students who were not performing well in class, although the referrals were few to none at each SM1 site. In addition, children whose numbers were randomly selected from total class lists as candidates for the comparison groups and who were found to meet criteria for FASD were included in the count of FASD cases. This latter process enabled identification of those with an FASD irrespective of growth deficits, and provided proportions generated from random selection from the entire first grade class enrollment for weighting used to estimate prevalence. In the situation where twin pairs were eligible for the study and one member of the pair screened positive or was randomly selected, the other twin was also selected for the evaluation.
Sampling Method 2 (SM2): A Simple Random Sample
The second approach was a totally random sample drawn from all children enrolled in first grade within a particular community in a given year. There was no oversampling on growth, and there were no teacher referrals. Instead, full evaluations for growth, dysmorphology, neurobehavior, and maternal drinking were completed for all children chosen randomly from the entire enrollment of the first-grade classes at the study schools who were consented by parents or guardians to participate in the study. We first drew a sample (30 -40%) from class lists of all enrolled children, explained the random nature of the sample to all parties in the community, and worked to gain consent for each selected child to participate in all aspects of the evaluation. Therefore, in SM2 all case and non-case children came from the random selection pool. Because there was no initial screening on growth, the full spectrum of FASD including cases with no growth deficits and children with ARND, were likely to be evaluated with no census or oversample of small children.
Sampling Method 3 (SM3): Oversample of Small Children or Children with Developmental Concerns and a Random Sample of Children with Neither
In this approach, consented children from the selected study schools were first screened on growth using the same criteria as SM1 (i.e., weight, height or head circumference ≤25 th centile). In addition, each consented child's parent or guardian completed the Parents' Evaluation of Developmental Status (PEDS) developmental assessment questionnaire. 2 All children who screened positive on growth and/or had two or more developmental concerns on the PEDS were selected to receive the full evaluation including the dysmorphology exam, neurobehavioral testing and assessment of maternal drinking. Consented children who had repeated the first grade in school were also considered screen positive and selected for the full evaluation, although this number was small. A random sample of consented children who screened negative on both growth and the PEDS developmental questionnaire was also selected for a comparison group, and received the full evaluations. Similar to SM1, children in the comparison group who met criteria for FASD were included in the case count for FASD and removed from the comparison group.
Dysmorphology Examination and FASD Categories
The dysmorphology evaluations for each child were conducted by one or more of a team of pediatricians at each site with specialized training and expertise in clinical genetics and dysmorphology and each was highly experienced in the diagnosis of FASD. Each exam was assisted on-site by a support team and scribe. The dysmorphologists used a standard examination form checklist including the cardinal facial features of FAS as well as multiple alcohol-associated minor anomalies (eFigure 1). Standard measurement equipment, reference charts for centiles, 1 palpebral fissure length, 3 inner canthal distance, outer canthal distance, and lip/philtrum guides 4 were used across sites. 5 As part of the physical evaluation, dysmorphologists also recorded the presence of Alcohol-Related Birth Defects (ARBD; e.g., heart or musculoskeletal defects) when such major structural anomalies were detected and additional information was available. However, ARBD as part of the FASD spectrum was not systematically evaluated as part of the CoFASP study and therefore is not included in the prevalence estimates. In addition, dysmorphologists documented alternative or suspected non-alcohol-related diagnoses, including genetic disorders, that may have ruled out FASD. Most evaluations were performed at the school sites, but in a small number of cases exams were performed at the study research office or the participant's home.
All examiners were blinded to the child's status regarding prenatal exposure to alcohol or neurobehavioral performance at the time of the physical exam. Two-dimensional (2D) facial images of children were captured at the time of the dysmorphology examination for purposes of assessing reliability of the qualitative assessment of features across multiple examiners. These images were used in the final case conferences held by the respective investigative teams to refresh memory of the dysmorphologists and examination team as findings for each child were discussed in preparation for the classification of FAS, pFAS, ARND, or not FASD.
Maternal or Collateral Interviews
A common core of maternal risk questions was agreed upon by all collaborators and the advisory committee early in the consortium initiative. These questions assessed maternal risk and protective factors via interviews performed in person at the Midwestern, Rocky Mountain, and Southeastern sites and over the telephone in almost all cases at the Pacific Southwestern site. Interviewers were blinded to the status of the child on dysmorphology and neurobehavior.
General maternal health and childbearing questions, demographic information, specific alcohol and other drug use by quantity, frequency, and gestational timing, and social or legal problems related to alcohol were addressed in each interview. The questionnaires were designed to allow for collection of information from a consented collateral source if the biological mother of the consented child was not available.
Interview protocols utilized questions on nutrition and diet, general health, and drinking items that were formulated, sequenced, and arranged in an overall health context via a timeline follow-back methodology. 6, 7 The questions were designed to enhance recall and elicit accurate reporting of alcohol and other drugs consumed from a variety of sources and beverage types. 8, 9 Usual drinking patterns and drinking before pregnancy recognition were used to more accurately calibrate quantity and frequency of drinking during the index pregnancy. [10] [11] [12] [13] [14] [15] The sequencing of questions had been developed in similar population-based studies and was used because direct reporting of prenatal drinking may be under-reported in some settings. [16] [17] [18] [19] Retrospective reports of maternal drinking have been found to reflect higher levels of consumption than those reported during the prenatal period. 15, [19] [20] [21] [22] Each of the two research teams also included additional maternal risk questions that were unique to their respective settings. The design of the maternal questionnaires evolved from previous research on teratogens and FASD epidemiology.
12,23-26
Cognitive and Behavioral Performance
Psychologists or psychometrists performed the neurobehavioral evaluations for consented children. They performed these evaluations either at the school site or research offices, and were blinded to the dysmorphology findings or maternal alcohol history for each child. The domains, test battery, and criteria for assessing cognitive performance and behavior with multiple tests and checklists were agreed upon early in the consortium initiative. The instruments used are presented in eFigure2 by domain of assessment and by cutoffs used to classify neurobehavioral deficits in this study. The battery was selected to evaluate the research-based deficits known to occur in children who were prenatally exposed to alcohol. In addition, the battery was chosen for cultural-relevance and appropriateness for the populations under study, and for availability in English and Spanish. Each measure was a standardized, proprietary test or checklist that is commonly used by assessment professionals to evaluate children in the first grade age range, and each item is accessible through standard media.
Case Conferences for Classification of Cases
Final classifications were made in case conferences where the findings for each child in each domain were discussed in a structured, sequential, roundtable fashion. 5, 27 At each research team site, case conference participants included the site principal investigator and research team members who either performed or oversaw the dysmorphology examinations, neurobehavioral testing, or maternal interviews. While the findings were being presented and reviewed by the group, 2-dimensional digital photos of the child's face were projected to contextualize the data for the dysmorphologists and assessment team and to refresh memories of the dysmorphologist regarding the examination.
Consistency and Quality Assurance for the Dataset
In classifying children within the FASD continuum, consortium criteria were initially applied and later double-checked by the data managers for the research teams for consistency and accuracy. Classifications were then triple-checked by the consortium investigative teams by reciprocal exchange of all relevant data for all FASD cases and a sample of non-cases. Each team was blinded to the other team's classification for each case and was asked to determine whether the criteria had been applied accurately and consistently across sites. Where:
Subsample labels are defined as follows:
• S: Children that were small on the initial screening.
• S Q : Small children that had enough alcohol-related physical features on dysmorphology to meet criteria for FAS/pFAS.
• S D : Small children that did not have enough alcohol-related physical features to qualify for FAS/pFAS.
• SRS D : Small children selected in the random sample that did not have enough alcohol-related physical features to qualify for FAS/pFAS.
• NS: Children that were not small on the initial physical exam.
• RSNS: Children selected in the random sample that were not small on the initial physical exam.
• TR: Children who entered as a twin or referral.
E is the total number of children enrolled in all 1 st grade classrooms at the study site.
M is the number of children that were consented and screened.
M Subsample is the number of children among the M total that belong to the subsample indicated by the subscript.
N Subsample is the number of children in the subsample indicated by the subscript that consented and were seen for a dysmorphology exam.
The weights w are the proportions of children enrolled in the study in each subsample.
For the subsamples S, NS, and TR, = . For S Q and S D, = and = .
X FAS , X pFAS , and X ARND are the numbers of children classified with FAS, pFAS, and ARND, respectively. Where:
X FAS , X pFAS , and X ARND are the numbers of children classified as FAS, pFAS and ARND.
M is the total number of randomly selected 1 st grade children from school class rolls at the site.
N is the total number of randomly selected 1 st grade children from study school class rolls at the site who were consented into the study and received full evaluations. Where:
• SP: Children that screened positive on the initial growth screening.
• SN: Children that screened negative on the initial growth screening.
• RC: Children selected in the random sample.
M SP and M SN are the numbers of children among the M total that belong to the subsamples SP and SN, respectively. 
Variance Estimates and Confidence Intervals
To obtain confidence intervals for the prevalence estimates, the variance of the estimated prevalence was estimated by var( ) = var( ) , where = . For SM1 and SM2, the subsample variances are estimated by var = 1 . For SM3, cluster sampling (where cluster = school) was accounted for using nonparametric bootstrap, by resampling with replacement the clusters (i.e., schools) with 10,000 bootstrap runs. Bootstrap sampling was performed independently in the Screen Positive and Random Control subsamples in each sample. The prevalence was computed in each bootstrap sample, and the variance of the 10,000 prevalence statistics was computed to estimate var( ) and var( ). For all prevalence estimates, to ensure that the confidence interval bounds were between 0 and 1, the transformation ( ) = log log( ) was first applied. Normal confidence bounds of form ( ) ± se(g( )) where computed, where z is the 0.975 quantile of a standard normal distribution, se( ( )) = var( ( )) , and var( ( )) var( )/( log( )) by the delta method. The resulting interval was then back-transformed to the original scale. In Sample 2 for the Midwestern City there were no cases of FAS; here the confidence interval was computed as (0, 3/N) using the "Rule of 3" method, where N = 236 was the total number of children with a classification. 
Tools Used Cut-off Criteria
Differential Ability Scales -DASII Domains Evaluated = neurobehavioral domains that were assessed Types of Measures = the areas of functioning within each domain that were assessed Tools Used = the tools or tests used to assess the named area of functioning Cut-off Criteria = cut-offs were used to define the scores indicating impairment for the specified domains on each test Within the Cognitive Domain, arrows are used to align the types of measures assessed to the specific test/subtests used to evaluate each ability (e.g., the NEPSY Inhibition subtest was used to assess both executive functioning and memory, while both the NEPSY Visuomotor Precision subtest and the VMI were used to assess visual spatial abilities) Abbreviations: NEPSY: A Developmental Neuropsychological Assessment; VMI: Beery-Buktenica Developmental Test of Visual-Motor Integration; CBCL: Child Behavior Checklist; TRF: Teacher Report Form
eFigure3. Subpopulations in SM1 Coded by Color
Abbreviations: SM: Sampling Method; FAS: Fetal Alcohol Syndrome; pFAS: partial Fetal Alcohol Syndrome; ARND: Alcohol-related Neurodevelopmental Disorder. "Small" is defined as children that are ≤ 25th centile for height, weight, or head circumference. Below we give an example calculation of the estimated prevalence of ARND in the Midwestern City for SM1. The color-coded boxes in the figure represent the four subpopulations: screened small with alcohol-related physical features meeting criteria for FAS or pFAS (gold), screened small and randomly selected but insufficient number of alcohol related physical features to meet criteria for FAS or pFAS (green), randomly selected and not small (orange); and twin or teacher referral (purple). For each subpopulation, a prevalence term is computed from children in the subpopulation that have a full evaluation. The four prevalences are then weighted according to the proportion of consented and screened children in each subpopulation and are summed as follows: 
